Selfotel in Acute Ischemic Stroke | Zendy

Stephen M. Davis | Zendy; Kennedy R. Lees | Zendy; Gregory W. Albers | Zendy; HansChristoph Diener | Zendy; S. Markabi | Zendy; Goeril Karlsson | Zendy; John W. Norris | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Selfotel in Acute Ischemic Stroke

Author(s) -

Stephen M. Davis,

Kennedy R. Lees,

Gregory W. Albers,

HansChristoph Diener,

S. Markabi,

Goeril Karlsson,

John W. Norris

Publication year - 2000

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.31.2.347

Subject(s) - medicine , stroke (engine) , placebo , ischemic stroke , neuroprotection , randomized controlled trial , clinical trial , barthel index , acute stroke , anesthesia , physical therapy , ischemia , rehabilitation , mechanical engineering , alternative medicine , pathology , engineering , tissue plasminogen activator

Based on neuroprotective efficacy in animal models, we evaluated the N-methyl D-aspartate antagonist Selfotel in patients with ischemic stroke, after doses up to 1.5 mg/kg were shown to be safe in phase 1 and phase 2a studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research